enGene Therapeutics, Inc. (ENGN)
7.23
-0.04
(-0.55%)
USD |
NASDAQ |
May 01, 16:00
7.23
0.00 (0.00%)
After-Hours: 16:42
enGene Therapeutics Market Cap : 484.33M for May 1, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Achieve Life Sciences, Inc. | 233.19M |
| Oncolytics Biotech, Inc. | 101.60M |
| Aurinia Pharmaceuticals, Inc. | 2.042B |
| Edesa Biotech, Inc. | 145.67M |
| Lexaria Bioscience Corp. | 17.76M |
Market Cap Related Metrics
| PEG Ratio | -0.0667 |
| Price to Book Value | 1.720 |
| Price | 7.23 |
| Earnings Yield | -31.18% |
| PEGY Ratio | -0.0667 |